RJA
OGN icon

Raymond James & Associates’s Organon & Co OGN Stock Holding History

Raymond James & Associates’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-12,000
Closed -$49.2K – 4014
2022
Q4 		$49.2K Buy
+12,000
New +$307K ﹤0.01% 3720
2022
Q3 		– Sell
-15,400
Closed -$75K – 4081
2022
Q2 		$75K Sell
15,400
-21,700
-58% -$760K ﹤0.01% 3736
2022
Q1 		$69K Sell
37,100
-22,900
-38% -$783K ﹤0.01% 3879
2021
Q4 		$50K Buy
60,000
+28,800
+92% +$938K ﹤0.01% 3948
2021
Q3 		$36K Buy
+31,200
New +$998K ﹤0.01% 3948

Other funds holding OGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
SSM
Sound Shore Management Greenwich, Connecticut $2.98B AUM 22.67% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DRZID
DePrince Race & Zollo Inc (DRZ) Winter Park, Florida $5.29B AUM 20.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Raymond James & Associates's OGN Position: Q3 2024 in Review

Raymond James & Associates reduced its Organon & Co (OGN) stake by 69% in Q3 2024, selling an estimated $4.61M and leaving 102,157 shares worth $1.95M. The position accounts for ﹤0.01% of the portfolio, ranked #2242.

Raymond James & Associates first reported a position in OGN in Q2 2021 and has held it in 14 quarters since. The position peaked at $9.71M in Q1 2022. 724 funds tracked by Wall St. Rank hold OGN as of Q3 2024.

  • Raymond James & Associates held 102,157 shares of Organon & Co worth $1.95M as of Q3 2024.
  • Raymond James & Associates sold 222,322 Organon & Co shares in Q3 2024, an estimated $4.61M.
  • Organon & Co made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #2242 holding.
  • Raymond James & Associates first reported a position in Organon & Co in Q2 2021 and has held it in 14 quarters since.
  • Raymond James & Associates's Organon & Co position peaked at $9.71M in Q1 2022.
  • 724 funds tracked by Wall St. Rank held Organon & Co as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.